Advertisement

Topics

Ovid Therapeutc (OVID) Downgraded by Zacks Investment Research

01:24 EDT 22 Aug 2017 | Topix

According to Zacks, "Ovid Therapeutics Inc. is a biopharmaceutical company. It engaged in developing therapies for patients with rare neurological disorders.

Original Article: Ovid Therapeutc (OVID) Downgraded by Zacks Investment Research

NEXT ARTICLE

More From BioPortfolio on "Ovid Therapeutc (OVID) Downgraded by Zacks Investment Research"

Advertisement
Quick Search
Advertisement
Advertisement